They certainly know the trial design and all the deficiencies that make any conclusions from the trial specious. Something FDA will see very clearly when it is filed. Violated numerous FDA Guidances.
There is no future if the FDA rejects the DCVax-L application. NWBO will be dead.
Market Data 
Markets 
AI
